Citigroup’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.5M Buy
26,099
+4,935
+23% +$852K ﹤0.01% 1491
2025
Q1
$3.3M Buy
21,164
+116
+0.6% +$18.1K ﹤0.01% 1717
2024
Q4
$2.9M Sell
21,048
-220
-1% -$30.3K ﹤0.01% 1857
2024
Q3
$3.18M Sell
21,268
-4,013
-16% -$599K ﹤0.01% 1686
2024
Q2
$3.45M Buy
25,281
+5,305
+27% +$723K ﹤0.01% 1386
2024
Q1
$3.02M Buy
19,976
+952
+5% +$144K ﹤0.01% 1543
2023
Q4
$2.4M Sell
19,024
-13,553
-42% -$1.71M ﹤0.01% 1517
2023
Q3
$3.05M Buy
32,577
+8,257
+34% +$773K ﹤0.01% 1259
2023
Q2
$2.17M Sell
24,320
-9,368
-28% -$836K ﹤0.01% 1634
2023
Q1
$3.61M Buy
33,688
+14,913
+79% +$1.6M ﹤0.01% 1252
2022
Q4
$2.29M Buy
18,775
+17,496
+1,368% +$2.14M ﹤0.01% 1426
2022
Q3
$132K Sell
1,279
-318
-20% -$32.8K ﹤0.01% 3265
2022
Q2
$149K Sell
1,597
-306
-16% -$28.6K ﹤0.01% 3342
2022
Q1
$223K Sell
1,903
-534
-22% -$62.6K ﹤0.01% 3353
2021
Q4
$328K Sell
2,437
-1,111
-31% -$150K ﹤0.01% 3321
2021
Q3
$566K Sell
3,548
-200
-5% -$31.9K ﹤0.01% 2806
2021
Q2
$493K Buy
3,748
+2,408
+180% +$317K ﹤0.01% 3091
2021
Q1
$173K Sell
1,340
-531
-28% -$68.6K ﹤0.01% 3431
2020
Q4
$312K Sell
1,871
-898
-32% -$150K ﹤0.01% 2953
2020
Q3
$427K Sell
2,769
-472
-15% -$72.8K ﹤0.01% 2340
2020
Q2
$479K Buy
3,241
+422
+15% +$62.4K ﹤0.01% 2593
2020
Q1
$317K Sell
2,819
-736
-21% -$82.8K ﹤0.01% 2565
2019
Q4
$495K Buy
3,555
+2,354
+196% +$328K ﹤0.01% 2641
2019
Q3
$116K Buy
1,201
+154
+15% +$14.9K ﹤0.01% 3361
2019
Q2
$121K Buy
1,047
+454
+77% +$52.5K ﹤0.01% 3505
2019
Q1
$70K Buy
+593
New +$70K ﹤0.01% 3804
2018
Q2
Sell
-142
Closed -$9K 4966
2018
Q1
$9K Sell
142
-902
-86% -$57.2K ﹤0.01% 4498
2017
Q4
$42K Buy
+1,044
New +$42K ﹤0.01% 3882
2016
Q2
Sell
-50
Closed -$1K 4943
2016
Q1
$1K Buy
+50
New +$1K ﹤0.01% 5170
2015
Q3
Sell
-42
Closed -$1K 5205
2015
Q2
$1K Sell
42
-38
-48% -$905 ﹤0.01% 5299
2015
Q1
$1K Buy
+80
New +$1K ﹤0.01% 5306